Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
The latest cancer news from the U.S. government's principal agency for cancer research.-
NCI study identifies essential genes for cancer immunotherapy
A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients.
-
NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome
A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers.
-
NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers
The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations.
NCI Fact Sheets
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Asbestos Exposure and Cancer Risk
A fact sheet about asbestos, asbestos-related diseases, and who to contact for more information.
-
Prostate-Specific Antigen (PSA) Test
A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.
-
Hormone Therapy for Breast Cancer
A fact sheet that describes hormone therapy (including antiestrogens, LH-RH agonists, aromatase inhibitors, and SERMs) and its role in preventing and treating breast cancer. Includes information about possible side effects.
